Amphastar's Q2 2024 revenue grew 25% year-over-year to $182.4 million, primarily driven by BAQSIMI and Primatene MIST sales ... Amphastar does have $586.853 million in long-term debt, partly ...
Some results have been hidden because they may be inaccessible to you